ETST - Earth Science Tech, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0950
+0.0050 (+5.56%)
At close: 3:12PM EST
Stock chart is not supported by your current browser
Previous Close0.0900
Open0.0950
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0900 - 0.0950
52 Week Range0.0600 - 0.9500
Volume30,176
Avg. Volume48,115
Market Cap5.055M
Beta (5Y Monthly)2.97
PE Ratio (TTM)N/A
EPS (TTM)-0.0320
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Emerging Markets Report - Earth Sciences Tech Inc at the Forefront of the CBD Revolution

    CBD exhibits every characteristic of a budding and promising industry. From an investment perspective, this presents a ground level opportunity for those who have the foresight, means, and (to be quite frank) courage to wager on an industry’s growth potential while still in its nascent phase. Earth Sciences Tech Inc (ETST) is one company jostling for space on the cutting edge of this new industry.

  • GlobeNewswire

    SmallCap Sentinel:  A Turning Point for CBD

    Opportunistic bears and short sellers on cannabis stocks have frightened investors with predictions of the end of the cannabis business based on the vaping scare. The news bodes well for CBD entrants like Earth Science Tech, Inc. (ETST), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development. It is compelling that Earth Science has real life science qualifications and isn’t just a new entry chasing the CBD gold rush.

  • GlobeNewswire

    Earth Science Tech Inc. (ETST) Names Pharmaceutical and Orthopedic Expert as Head of New Sales Division

    Earth Science Tech Inc. (ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, announces it has established a new sales division to sharpen its focus on CBD for therapeutic and pharmaceutical-grade products. Leading the division will be Erika Franck, who for several weeks has productively served as the Company’s clinical and therapeutics sales director. ETST formed the new sales division in response to increased CBD interest within the medical, holistic and alternative medical communities and among licensed professionals.

  • GlobeNewswire

    Earth Science Tech, Inc. (ETST) Premiered Kevin Harrington's 'As Seen On TV' Infomercial Featuring Client Testimonial Has Commenced

    Earth Science Tech, Inc. (ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, announces that its highly-anticipated As Seen On TV 60-second spot infomercial with esteemed entrepreneur Kevin Harrington began airing, April 23, 2019, in the New York City viewership area.

  • GlobeNewswire

    Earth Science Tech Engages Consultant to Lead Dual Listing Compliance

    Earth Science Tech, Inc. (ETST) (“ETST” or the “Company”), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, announces that it has engaged Derek Lindsay as a consultant to manage compliance for the potential dual listing of the Company’s common shares on the Canadian Securities Exchange (the “CSE”) in addition to its current listing on the OTCQB.

  • GlobeNewswire

    Earth Science Tech, Inc.-sponsored Foundation achieves Non-Profit Status to advance research on cannabinoids.

    Earth Science Tech, Inc. (ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, is pleased to share that Earth Science Foundation, Inc. (“Foundation”), the creation of which it has supported, is now a 501(c)(3) organization. Obtaining non-profit status enables the Foundation to accept tax-free contributions that will fund further studies of cannabidiol (“CBD”) products with a primary object of helping those who suffer from cancer, epilepsy, depression, autism, chronic pain, dementia, drug/alcohol addiction, and AIDS.

  • GlobeNewswire

    Earth Science Tech, Inc. Signs Distributor for Hygee™ and Provides Update on CBD Product Launch

    Earth Science Tech, Inc. (ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today announces a distribution agreement to market its Hygee™ medical device in Vietnam, as well as provides an update on its CBD product line.

  • GlobeNewswire

    Earth Science Tech, Inc. (ETST) Signs Agreements to Distribute CBD Products through Pharmacies, Chiropractors, Dispensaries, Athletic Clubs and Clinics

    DORAL, Florida, Feb. 06, 2019 -- Earth Science Tech, Inc. (OTCQB: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD),.

  • GlobeNewswire

    Earth Science Tech, Inc. (ETST) to Exhibit Hygee™ at the Arab Health Medical Trade Fair in Dubai

    Earth Science Tech, Inc. (ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today announces that it will display its leading-edge medical device, Hygee™, at Arab Health 2019 in Dubai, the biggest annual medical trade fair in the Middle East & North Africa (MENA) region. The Arab Health 2019 fair will take place January 28 – 31, 2019, at the Dubai World Trade Centre, where manufacturers and medical service providers can connect with clinicians, procurement professionals, dealers and distributors.

  • GlobeNewswire

    Earth Science Tech, Inc. (ETST) Partners with Iq2 Labs to Formulate a CBD Mental Clarity and Focus Shot, High Grade Full Spectrum Iq2 Cannabinoids

    DORAL, Florida, Jan. 23, 2019 -- Earth Science Tech, Inc. (OTCQB: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical.